Clinical Trial Update: Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101 [Phase 1]

View source ↗

Summary

Phase I trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of LYN101 in individuals with osteoporoti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Osteoporotic Fracture

Drugs mentioned

• LYN101

Snippet

Sponsor: Shanghai TTM-Bio Technology Co., Ltd | Conditions: Osteoporotic Fracture | Phase 1 | Status: ENROLLING_BY_INVITATION